A Dual-Type L2 11-88 Peptide from HPV Types 16/18 Formulated in Montanide ISA 720 Induced Strong and Balanced Th1/Th2 Immune Responses, Associated with High Titers of Broad Spectrum Cross-Reactive Antibodies in Vaccinated Mice

<table class="table-group" id="tab1"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td class="align_left">Groups</td><td class="align_center">Immunogen</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td class="align_left">G1</td><td class="align_center">(HPV 16) 17-36 × 3 + (HPV 18) 17-36 × 3 in CFA/IFA</td></tr><tr><td class="align_left">G2</td><td class="align_center">(HPV 16) 69-81 × 3 + (HPV 18) 69-81 × 3 in CFA/IFA</td></tr><tr><td class="align_left">G3</td><td class="align_center">(HPV 16) 11-88 × 1 + (HPV 18) 11-88 × 1 in CFA/IFA</td></tr><tr><td class="align_left">G4 (control group)</td><td class="align_center">CFA/IFA</td></tr><tr><td class="align_left">G5 (control group)</td><td class="align_center">PBS</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr><tr class="table-fn"><td><div>CFA and IFA denote the complete and incomplete Freund adjuvants, respectively. CFA was used for formulation of the immunogen in first immunization and IFA for next immunizations. Control groups are deprived from antigen.<br/></div></td></tr></table>

<div>Group of mice immunized with different dual-type L2 peptides formulated in CFA/IFA.</div>

Journal of Immunology Research

tab1

Table 1

Table 1: A Dual-Type L2 11-88 Peptide from HPV Types 16/18 Formulated in Montanide ISA 720 Induced Strong and Balanced Th1/Th2 Immune Responses, Associated with High Titers of Broad Spectrum Cross-Reactive Antibodies in Vaccinated Mice 

Table 1 | A Dual-Type L2 11-88 Peptide from HPV Types 16/18 Formulated in Montanide ISA 720 Induced Strong and Balanced Th1/Th2 Immune Responses, Associated with High Titers of Broad Spectrum Cross-Reactive Antibodies in Vaccinated Mice 